Simsen Diagnostics will exhibit at the ESMO Congress 2026 in Madrid, 23 to 27 October, at IFEMA, Hall 8, booth 8043. If your work touches ctDNA monitoring, in clinical trials, in the laboratory or in the clinic, this is the easiest week of the year to sit down with our team in person.
The ESMO Congress is Europe's largest oncology meeting, gathering clinicians, researchers and industry from across the world. For five days, the conversations that usually take weeks of emails and video calls can happen across a table.
Whether tumour-informed ctDNA monitoring fits your samples is a question best answered in person, with your tumour types, your sample logistics and your timelines on the table. At the booth you can work through:
Method fit for your question. ctDNA monitoring approaches are not interchangeable: SNV-based, SV-based and tumour-naive methods each suit different tumour types and study designs. We will tell you honestly which fits your case, including when it is not us.
Where the test runs, and who holds the data. Run monitoring as a full service from our EU laboratory, or bring the method into your own laboratory with LabSuite on the Illumina sequencers you already own. Either way, samples and data stay in the EU and the raw sequencing data is yours.
A monitoring panel from the material you actually have. Tumour tissue, or existing sequencing data where no fresh biopsy is available: bring your starting point and we will map the route to a personalised panel.
Meeting slots during the congress fill quickly. To reserve a time with the team at booth 8043, contact us here and mention ESMO. Drop-by visitors are always welcome too: Hall 8, booth 8043, on the corner by the catering area.
Simsen Diagnostics provides tumour-informed ctDNA analysis for European oncology, built on the peer-reviewed SiMSen-Seq method. Each patient's own tumour mutations are tracked in plasma or cerebrospinal fluid over time, delivered as a full service from our laboratory in Mölndal, Sweden, or in-house in your own laboratory. All analysis is performed within the EU.